Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-06-12 @ 11:57 PM
Study NCT ID:
NCT01924260
Status:
COMPLETED
Last Update Posted:
2022-08-02
First Post:
2013-08-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
Sponsor:
Edward Kim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acinar Cell Adenocarcinoma of the Pancreas | View |
| None | Duct Cell Adenocarcinoma of the Pancreas | View |
| None | Recurrent Pancreatic Cancer | View |
| None | Stage III Pancreatic Cancer | View |
| None | Stage IV Pancreatic Cancer | View |
| None | Unspecified Adult Solid Tumor, Protocol Specific | View |
Keywords: